Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Having -c- – wherein x is chalcogen – bonded directly to...
Reexamination Certificate
2011-04-19
2011-04-19
Spivack, Phyllis G. (Department: 1614)
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Having -c-, wherein x is chalcogen, bonded directly to...
Reexamination Certificate
active
07928115
ABSTRACT:
Treatment of traveler's diarrhea in subjects having hepatic encephalopathy using rifaximin is disclosed.
REFERENCES:
patent: 4343785 (1982-08-01), Schmolka
patent: 4557866 (1985-12-01), Cannata et al.
patent: 2004/0106590 (2004-06-01), Eisenstein
patent: 2005/0272754 (2005-12-01), Viscomi et al.
patent: 2008/0262012 (2008-10-01), Viscomi et al.
patent: 2009/0028940 (2009-01-01), Jahagirdar et al.
patent: 2009/0088423 (2009-04-01), Sayada
patent: 2009/0130201 (2009-05-01), Viscomi et al.
patent: 2009/0149453 (2009-06-01), Sayada
patent: 2010/0069421 (2010-03-01), Bettenhausen
patent: 2010/0174064 (2010-07-01), Gushurst et al.
patent: 2010/0239664 (2010-09-01), Gushurst et al.
Package Insert for the commercial product Xifaxan tablets from Physicians Desk Reference (PDR), (retreived Jan. 2010), http://www.pdrel.com/View/Common/PrintReady.
Adachi et al., Clinical Infectious Diseases, 42 (Feb. 15, 2006), pp. 541-547.
Gerard et al. Expert Reviews of Anti Infective Therapeutics 3(2):201-211 (2005).
Jiang et al. European Journal of Gastroenterology & Hepatology 20:1064-1070 (2008).
Adachi et al. Reviews of Anti-Infective Agents 42: 541-547 (2006).
Prescribing Information For Rifaximin, United States, May 2004.
Prescribing Information For Rifaximin, United States, Jan. 2007.
Prescribing Information For Rifaximin, United States, Mar. 2010.
Prescribing Information For Rifaximin, Italy, Apr. 23, 1985.
Prescribing Information For Rifaximin, Korea, Jan. 2006.
Prescribing Information For Rifaximin, Lebanon, Dec. 2002.
Prescribing Information For Rifaximin, Romania, Nov. 2005.
Prescribing Information For Rifaximin, Tunesia, Mar. 2004.
Prescribing Information For Rifaximin, Spain, Date Unknown, but after Apr. 23, 1985.
Prescribing Information For Rifaximin, Bulgaria, Jun. 2007.
Prescribing Information For Rifaximin, Argentina, Date Unknown, but after Apr. 23, 1985.
Prescribing Information For Rifaximin, Austria Nov. 2005.
Prescribing Information For Rifaximin, Hungary Apr. 2004.
Prescribing Information For Rifaximin, Slovakia Sep. 2003.
Prescribing Information For Rifaximin, Russia, Date Unknown, but after Apr. 23, 1985.
Prescribing Information For Rifaximin, Greece 2001.
Prescribing Information For Rifaximin, Mexico Jul. 2007.
Prescribing Information For Rifaximin, Poland Apr. 2006.
Prescribing Information For Rifaximin, Venezeula Sep. 2008.
Prescribing Information For Rifaximin, Czech Republic Mar. 2008.
Prescribing Information For Rifaximin, Turkey Sep. 2007.
Prescribing Information For Rifaximin, China, Oct. 2006.
Prescribing Information For Rifaximin, Portugal Date Unknown, but after Apr. 23, 1985.
Pharmacology/Toxicology Review of Rifaximin by the FDA, Apr. 26, 2004.
Bortey Enoch
Forbes William
McCarter & English LLP
Salix Pharmaceuticals, Ltd.
Sparks Jonathan M.
Spivack Phyllis G.
LandOfFree
Methods of treating travelers diarrhea and hepatic... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Methods of treating travelers diarrhea and hepatic..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Methods of treating travelers diarrhea and hepatic... will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2631551